Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer

被引：0
|
作者：
Lisa M. C. van Hoogstraten
Calvin C. O. Man
J. Alfred Witjes
Richard P. Meijer
Sasja F. Mulder
Tineke J. Smilde
Theodora M. Ripping
Lambertus A. Kiemeney
Katja K. H. Aben
机构：
[1] Netherlands Comprehensive Cancer Organisation,Radboud Institute for Health Sciences
[2] Radboud University Medical Centre,Department of Urology
[3] Radboud University Medical Centre,Department of Oncological Urology
[4] University Medical Centre Utrecht,Department of Medical Oncology
[5] Radboud University Medical Centre,Department of Medical Oncology
[6] Jeroen Bosch Hospital,undefined
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Bladder carcinoma; Guideline adherence; MIBC; Muscle-invasive bladder cancer; Neoadjuvant chemotherapy; Radical cystectomy; Variation in healthcare;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1837 / 1845
页数：8
相关论文
共 50 条
  • [41] Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
    Beije, N.
    de Kruijff, I. E.
    de Jong, J. J.
    Klaver, S. O.
    de Vries, P.
    Jacobs, R. A. L.
    Somford, D. M.
    te Slaa, E.
    van der Heijden, A. G.
    Witjes, J. Alfred
    Fossion, L. M. C. L.
    Boeve, E. R.
    van der Hoeven, J.
    van Melick, H. H. E.
    Wijburg, C. J.
    Bickerstaffe, H.
    Martens, J. W. M.
    de Wit, R.
    Kraan, J.
    Sleijfer, S.
    Boormans, J. L.
    ESMO OPEN, 2022, 7 (02)
  • [42] Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
    Peyrottes, Arthur
    Ouzaid, Idir
    Califano, Gianluigi
    Hermieu, Jean-Francois
    Xylinas, Evanguelos
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [43] Neoadjuvant therapy for muscle-invasive bladder cancer
    Jain, Rohit K.
    Sonpavde, Guru
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (07) : 603 - 614
  • [44] Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
    Elsayed, Dalia Hamouda
    Elfarargy, Ola M.
    Elderey, Mohamed Salah
    Mandour, Doaa
    Atef, Nora
    Hemeda, Rehab
    Kamel, Mostafa
    Azony, Ahmed
    Taha, Heba F.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (01): : 1 - 9
  • [45] Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Is Low Among Major European Centres: Results of a Feasibility Questionnaire
    Burger, Maximilian
    Mulders, Peter
    Witjes, Wim
    EUROPEAN UROLOGY, 2012, 61 (05) : 1070 - 1071
  • [46] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: does variant histology matter?
    Catarino, Raquel
    Alves, Luisa
    Pereira, Diogo
    Costa, Gabriel
    Pereira, Joao
    Cardoso, Andre
    Braga, Isaac
    Freitas, Rui
    Correia, Tiago
    Cerqueira, Manuel
    Reis, Frederico Carmo
    Lobo, Francisco
    Silva, Vitor
    Magalhaes, Sanches
    Morais, Antonio
    Prisco, Rui
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (12) : 3163 - 3169
  • [47] Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Experience of a Single Institute in Taiwan
    Chou, Meng Han
    Kao, Chien Chang
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 436 - 436
  • [48] Predictive Biomarkers for Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer: A survey
    Abdeltawab, Hisham
    Khalifa, Fahmi
    Ghazal, Mohammed
    Haddad, Ahmed
    Mohamed, Tamer
    Giridharan, Guruprasad
    El-Baz, Ayman
    2018 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY (ISSPIT), 2018, : 423 - 428
  • [49] Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Are We Asking the Right Questions?
    Aragon-Ching, Jeanny B.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4169 - 4170
  • [50] Muscle-invasive bladder cancer: Molecular subtypes and response to neoadjuvant chemotherapy.
    Seiler, Roland
    Winters, Brian
    Douglas, James
    van Rhijn, Bas W. G.
    Sjodahl, Gottfrid
    Lerner, Seth P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345